FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Brilliant Blue G | .25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Remifentanil Hydrochloride | 50 ug/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Sodium Chloride | 1000 mg | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Chloride | 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride; Gentamicin Sulfate | 1 mg/.12 mL; 4 mg/.12 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 g | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Ceftazidime | 22.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Cefuroxime Sodium | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Ephedrine Sulfate | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Epinephrine Hydrochloride; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Aflibercept | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Qualgen LLC | 034474862 | 69761-112 | 69761-112-01 | Testosterone | 12.5 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-137 | 69761-137-01 | Testosterone | 37.5 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-120 | 69761-120-01 | Testosterone | 200 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-110 | 69761-110-01 | Testosterone | 100 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-150 | 69761-150-01 | Testosterone | 50 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-125 | 69761-125-01 | Testosterone | 25 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-187 | 69761-187-01 | Testosterone | 87.5 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-222 | 69761-222-01 | Testosterone; Anastrozole | 200 mg; 20 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-025 | 69761-025-01 | Estradiol | 25 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-010 | 69761-010-01 | Estradiol | 10 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-018 | 69761-018-01 | Estradiol | 18 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-012 | 69761-012-01 | Estradiol | 12.5 mg | 2019-1 | valid | 2026-11-14 | |
| Qualgen LLC | 034474862 | 69761-020 | 69761-020-01 | Estradiol | 20 mg | 2019-1 | valid | 2026-11-14 | |
| QuVa Pharma | 079937015 | Fentanyl Citrate | 5 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 10 ug/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 1 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate | 100 ug/2 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 156.25 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 |